The Gateway to Algorithmic and Automated Trading

Trade automation: panacea or placebo?

Itiviti : Cecilia Razelli - 31st October 2017

The opinions expressed by this blogger and those providing comments are theirs alone, this does not reflect the opinion of Automated Trader or any employee thereof. Automated Trader is not responsible for the accuracy of any of the information supplied by this article.

Automation throughout the trading process is increasing rapidly, but there are roles for human agency, according to participants at a roundtable discussion in New York City held in June 2017.

This video and article sum up the main points covered during the panel, including:

  • The role of regulation in driving trade automation;
  • Machine learning and artificial intelligence;
  • Technology transfer across desks and asset classes;
  • Data integrity and quality.

Participants included:

  • Jim Northey, Senior Vice President, Strategy and Research, Itiviti
  • Leo Li, Senior Investment Project Manager, The Vanguard Group
  • Adrian Facini, Product and Program Management, IEX Group
  • James Rubinstein, Americas Head of Algorithmic Trading and Analytics, UBS
Download the article summary

The post Trade automation: panacea or placebo? appeared first on Itiviti.

  • Copyright © Automated Trader Ltd 2018 - Strategies | Compliance | Technology

click here to return to the top of the page
content